Nvidia-backed AI firm Iambic unveils drug discovery ‘breakthrough’

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs. Iambic, which has previously won investment from tech giant Nvidia, published details of its new AI drug discovery model, named "Enchant". Enchant was trained on large troves of pre-clinical data, derived from laboratory tests conducted on drugs before they were ever tested on humans.